Donald Picker

Donald H.
Picker is the founder of Moleculin Biotech, Inc., founded in 2015, where the title held is Chief Scientific Officer.
Current jobs include Chief Executive Officer & Director at Sinapis Pharma, Inc., President & Chief Operating Officer at Moleculin LLC since 2007, and Chief Technology Officer at Secure Voice Communications, Inc. since 2007.
Former jobs include Chief Executive Officer at Synergy Pharmaceuticals, Inc. from 1998 to 2003; Chief Executive Officer at Intertech Bio; Vice Chairman & President at Interactive Therapeutics, Inc.; Director at Cardiff Oncology, Inc. in 2009; President, Chief Operating Officer & Director at Breitling Energy Corp.; Director at CNS Pharmaceuticals, Inc. from 2018 to 2019; President & Chief Operating Officer at Tapestry Pharmaceuticals, Inc. from 2006 to 2007; Vice President-Research & Development at Callisto Pharmaceuticals, Inc. from 2001 to 2006; Executive Vice President-Research & Development at Genta, Inc.; and Chief Operating Officer at Edgeline Holdings, Inc. from 2007 to 2008.
Education includes a doctorate from State University of New York at Albany conferred in 1975 and an undergraduate degree from New York University Tandon School of Engineering.